Bristol Myers Squibb will build a massive advanced manufacturing and life sciences facility in Houston's Generation Park, ...

The roughly 600,000-square-foot facility at Generation Park will create nearly 500 permanent jobs and about 2,000 ...

The deal blew up when the FT reported on Aug. 2 about the potential tie-up between pharmaceutical giants, the FT said. AstraZeneca ( AZN) shares plunged 9% in London on Aug. 3. By the evening of Aug.

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new ...

The approximately 600,000-square-foot campus will be designed to manufacture multiple types of medicines and is expected to create nearly 500 skilled jobs.

U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

The move marks the second major pharmaceutical firm to choose the Houston development site since 2025, following Eli Lilly.

Bristol Myers Squibb has laid out plans for a $2.3 billion manufacturing facility in Houston, set for completion in 2030. The plant will cover 600,000 square feet and employ nearly 500 people.

Bristol Myers Squibb (NYSE:BMY) today announced the selection of Houston, Texas, as the site for a new, state-of-the-art multi-modal manufacturing campus, representing an approximately $2.3 billion ...

Major pharmaceutical company Bristol-Myers Squibb plans to open a 70,000-square-foot facility in Hillsborough County and fill ...

Last week, reports emerged of a potential merger between AstraZeneca and Bristol Myers Squibb. While a senior source reportedly debunked these rumors days later, the news caused an uproar across the ...

Another major pharmaceutical corporation officially committed to a $2.3 billion manufacturing site in Houston with 500 full-time jobs.